To understand whether the mutated SF3B1 expression has an apparent impact on response to the MDM2 inhibitors, the LC50 values of RG7388 for the p53 functional (TP53WT) CLL samples were plotted against the SF3B1 status. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.